As simple as it may seem, there are many challenges associated with the procedure, including its high cost and a limited availability of donor islets. Transplantation also requires lifelong use of ...
Specifically, nearly two-thirds of consultants are seeing a rise in demand for guidance on specialty drug cost management, as revealed by the 2024 Benefits Consultants’ Sentiment Index (The ...
A recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps between high- and low-income countries. The ...
However, drugmakers argue that covering these drugs can reduce long-term expenses by preventing obesity-related health issues, workers compensation claims and disability costs. This is ...
The two biggest drivers of the expected costs are an estimated $165 million in price hikes for medical care and $41 million tied to the high price tag of new classes of drugs used to treat obesity, ...
Image source: Getty Images. 2. Out-of-pocket cap on prescription drugs The out-of-pocket cap is for Medicare Part D, which helps Medicare enrollees cover the cost of prescription drugs they need.
The design of a cost-effective ... of the individual drugs that make up the typical immunotherapy regimen for kidney and pancreas transplantation. The most commonly used immunosuppressive regimen ...
Immunosuppressive protocols are not ... responses to therapy and drug tolerability. Furthermore, costs should be viewed as a potential complication or side effect of immunotherapy, and therefore ...